Actuate Therapeutics, Inc Common stock

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
EBITDA
-4,687
-5,402
-5,944
-6,311
EBIT
-5,968
-12,731
Net Income
-4,553
-5,407
-5,949
-6,317
Net Change In Cash
0
0
0
0
Free Cash Flow
-3,736
-6,677
-4,348
-4,618
Cash
13,159
16,924
6,492
3,889
Basic Shares
23,245
21,394
19,646
19,497

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
EBITDA
-22,495
-25,160
-24,428
-20,079
EBIT
-27,304
-24,700
-20,143
Net Income
-22,227
-27,285
-24,744
-20,159
Net Change In Cash
0
0
0
0
Free Cash Flow
-19,206
-21,842
-21,625
-17,794
Cash
13,159
8,641
2,958
20,449
Basic Shares
21,021
19,514
15,033
15,033

Earnings Calls

QuarterEPS
2025-12-31
-$0.18
2025-09-30
-$0.25
2025-06-30
-$0.30
2025-03-31
-$0.32